文献速递功能神经外科

微血管减压术与伽玛刀治疗原发性三叉神经痛的有效性与安全性:一项前瞻性研究

Efficacy and Safety of Microvascular Decompression and Gamma Knife Surgery Treatments for Patients with Primary Trigeminal Neuralgia: A Prospective Study.
PubMed 文献 · World Neurosurg · 2018-04-26

这项前瞻性研究将441例原发性三叉神经痛患者随机分为微血管减压术组(220例)和伽玛刀组(221例),随访2年。微血管减压术组完全疼痛缓解率83%,显著优于伽玛刀组的25%;两组复发率无显著差异(0.45% vs 0.9%),但微血管减压术组严重并发症更多。

要点

  • 微血管减压术组2年完全疼痛缓解率83%,伽玛刀组为25%。
  • 两组复发率无显著差异(0.45% vs 0.9%)。
  • 微血管减压术组严重并发症多于伽玛刀组。

核心结论

  • 微血管减压术和伽玛刀均是治疗三叉神经痛的有效手术方法。
  • 微血管减压术组的完全疼痛缓解率显著优于伽玛刀组。
  • 两组复发率无显著差异,但微血管减压术组严重并发症多于伽玛刀组。

研究设计与样本

  • 前瞻性研究,将原发性三叉神经痛患者随机分为微血管减压术组和伽玛刀组,随访2年评估疗效、复发率和并发症。
  • 共纳入441例患者,微血管减压术组220例,伽玛刀组221例。

主要发现

  • 两组均无死亡病例。
  • 2年随访时,微血管减压术组183例(83%)完全疼痛缓解,5例(2%)明显缓解,20例(9%)无缓解。
  • 伽玛刀组55例(25%)完全疼痛缓解,106例(48%)明显缓解,37例(17%)无缓解。
  • 两组复发率无显著差异(0.45% vs 0.9%)。
  • 微血管减压术组最常见并发症为化学性脑膜炎(6%)、脑脊液漏(4%)和面瘫(4%);伽玛刀组最常见并发症为角膜反射消失(6%)和面部麻木(5%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare efficacy and safety of microvascular decompression (MVD) and Gamma Knife surgery (GKS) treatments for trigeminal neuralgia. METHOD: Patients with primary trigeminal neuralgia were randomly divided into 2 groups to undergo either MVD or GKS. All patients were followed for 2 years to evaluate efficacy, recurrence rates, and complications of treatment. RESULTS: Of 441 enrolled patients, 220 were in the MVD group, and 221 were in the GKS group. There were no deaths in either group. At the 2-year follow-up, 183 patients (83%) in the MVD group reported complete pain relief, 5 (2%) had obvious pain relief, and 20 (9%) had no relief. In the GKS group, 55 patients (25%) reported complete pain relief, 106 (48%) had obvious pain relief, and 37 (17%) had no relief. There was no significant difference in the recurrence rate (0.45% vs. 0.9%) between the 2 groups. The most common complications in the MVD group were chemical meningitis (6%), cerebrospinal fluid leakage (4%), and facial palsy (4%). Loss of corneal reflex (6%) and facial numbness (5%) were the most common complications in the GKS group. CONCLUSIONS: Both MVD and GKS are effective surgical treatments for trigeminal neuralgia. The rate of complete pain relief in the MVD group was significantly superior to the rate of complete pain relief in the GKS group. There was no significant difference in recurrence rates between the groups; however, there were more severe complications in the MVD group than in the GKS group.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zeng YJ, Zhang H, Yu S, et al. Efficacy and Safety of Microvascular Decompression and Gamma Knife Surgery Treatments for Patients with Primary Trigeminal Neuralgia: A Prospective Study. World Neurosurg. 2018. PMID: 29705231. doi:10.1016/j.wneu.2018.04.120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。